1. E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation. Issue 10 (1st July 2022) Authors: Ling, Sunbin; Zhan, Qifan; Jiang, Guangjiang; Shan, Qiaonan; Yin, Lu; Wang, Rui; Que, Qingyang; Wei, Xuyong; Xu, Shengjun; Yu, Jiongjie; Zhou, Wei; Zhang, Lincheng; Bao, Jiaqi; Ye, Qianwei; Su, Renyi; Wei, Rongli; Liu, Jimin; Chen, Kangchen; Wang, Jingrui; Xie, Haiyang Journal: American journal of transplantation Issue: Volume 22:Issue 10(2022) Page Start: 2323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Systemic analysis identifying PVT1/DUSP13 axis for microvascular invasion in hepatocellular carcinoma. (16th December 2022) Authors: Su, Renyi; Zhang, Huizhong; Zhang, Lincheng; Khan, Abdul Rehman; Zhang, Xuanyu; Wang, Rui; Shao, Chuxiao; Wei, Xuyong; Xu, Xiao Journal: Cancer medicine Issue: Volume 12:Number 7(2023) Page Start: 8937 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The ongoing trends of patient‐derived xenograft models in oncology. Issue 11 (20th September 2020) Authors: Zhuo, Jianyong; Su, Renyi; Tan, Winyen; Lian, Zhengxing; Lu, Di; Xu, Xiao Journal: Cancer communications Issue: Volume 40:Issue 11(2020) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗